Northwire Canada EditionSaturday, July 11, 2026
Sign inSubscribe
Northwire
⌕
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
Earnings Routine −

Birchtech Reports First Quarter 2026 Financial Results

Birchtech Cash Buoyancy Masks Operational Burn as Legal Judgment Remains Unresolved

By The Northwire Desk — AI Analysis May 13, 2026 · 16:05 BCHT · 1.82 BIRCHTECH CORP
Executive Summary
  • Birchtech reported Q1 2026 revenues of $4.2 million, a 32% increase year-over-year compared to Q1 2025.
  • Net loss widened quarter-over-quarter to $1.3 million ($0.06 per share) from $0.6 million in Q4 2025, though improved year-over-year from $1.7 million.
  • Cash position strengthened significantly to $14.7 million as of March 31, 2026, up from $2.2 million at December 31, 2025.
  • Company launched SEA-IX™ nuclear-grade ion exchange resin product line with approximately $1 million in initial purchase orders.
  • Pursuing enforcement of a $78 million patent infringement judgment; defendants have filed an appeal but have not posted a bond.
  • Management appointed Michael Mioska as Chief Financial Officer in May 2026.
  • SG&A expenses decreased to $2.0 million from $2.2 million, while R&D expenses increased to $0.6 million from $0.4 million.
Material Impact
  • The cash position improvement is material and positive for solvency, extending runway by approximately 10 quarters at current burn rates.
  • However, the widening net loss quarter-over-quarter ($0.6M to $1.3M) indicates operational inefficiency or accelerated spending that offsets revenue growth.
  • The $78 million judgment remains a material risk factor; while legally secured, the appeal and lack of posted bond create uncertainty regarding actual cash realization.
  • Revenue growth is positive but absolute scale ($4.2M quarterly) remains small relative to the company's valuation history and legal claims.
  • The market has already priced in significant downside (price drop from $6.70 to $1.82), suggesting this news is largely expected or insufficient to reverse sentiment without confirmed judgment collection.
BCHT · Price
Company Overview
  • Birchtech Corp. operates in environmental technology, focusing on air purification (mercury emissions) and water treatment (PFAS removal).
  • Flagship Project: SEA-IX™ nuclear-grade ion exchange resin line targeting the $220 million addressable market for nuclear/coal/municipal water.
  • Secondary Platform: Carbon Rejuvenation™ process for PFAS removal using thermally rejuvenated granular activated carbon.
  • Legal Asset: Patent infringement judgment against CERT defendants totaling approximately $78 million plus interest.
Read the original news release →

More from BIRCHTECH CORP

Jun 03, 2026 · 08:31

Birchtech Clears Final Patent Hurdles, But $78M Judgment Collection and Early-Stage Water Ramp Remain the True Valuation Drivers

Regulatory Mar 31, 2026 · 16:05

Birchtech Secures Capital and Court Win, But Profitability and Appeal Risks Cap Upside

Earnings Mar 30, 2026 · 19:25

Birchtech releases SEA-IX ion exchange resin line

Other Mar 30, 2026 · 08:31

BCHT

Other Mar 03, 2026 · 08:31

Birchtech Issues Shareholder Letter and Provides Corporate Update

Production / Operations Feb 26, 2026 · 18:05

Birchtech prices $15-million public offering

Financings